 |
|
Sign in to view your progression
|
The ISTH webinar series will provide high quality and state of the art education to practitioners around the world. Throughout the course of the year, the series will provide both clinical and basic science education in the areas of Thrombosis and Anticoagulation; Platelets and Vascular Biology; Coagulation and Bleeding Disorders.
- Learners will recognize the underlying causes of bleeding and clotting disorders and improve their evaluation of patients
- Speakers will discuss the latest treatments and therapies to allow learners to analyze which advancements will benefit their patients
- Researchers will be presented with the latest research in thrombosis and hemostasis in order to identify relationships with their own research and/or clinical applications
Planning Committee:
Geoffrey Barnes, MD, MSc
Meera Chitlur, MD
Caterina Casar, PhD
All persons in control of content have NO relevant financial relationships to disclose with the exception of the following persons:
Geoffrey Barnes, MD, MSc
Company: BMS/Pfizer, NHLBI, Blue Cross Blue Shield of Michigan, Portola Janssen
Role: Research Investigator, Consultant
Meera Chitlur, MD
Company: Bayer, Genentech, Novo nardisk, Baxter
Role: Advisory Board, Consultant, Speaker
|
Hemostatic complications in patients on ECMO and VADs
|
|